• Shopping Cart
    There are no items in your cart

DD ISO/TS 12417:2011

Superseded

Superseded

View Superseded by

Cardiovascular implants and extracorporeal systems. Vascular device-drug combination products

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

07-31-2011

Superseded date

10-31-2015

Superseded by

BS EN ISO 12417-1:2015

US$462.87
Excluding Tax where applicable
Summarise this standard

Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General requirements
5 Intended performance
6 Design attributes
7 Materials
8 Design evaluation
9 Post-market surveillance
10 Manufacturing
11 Sterilization
12 Packaging
Annex A (informative) - Definitions of potential
        clinical events
Annex B (informative) - Information on device- and
        drug-related aspects - Applicable documents
        for local guidance
Bibliography

Describes requirements for vascular device-drug combination products (VDDCPs) based upon current technical and medical knowledge. VDDCPs are medical devices with various clinical indications for use in the human vascular blood system. A VDDCP incorporates, as an integral part, substance(s) which, if used separately, can be considered to be a medicinal product (drug product) but the action of the medicinal substance is ancillary to that of the device and supports the primary mode of action of the device.

Committee
CH/150/2
DocumentType
Standard
Pages
60
PublisherName
British Standards Institution
RevisionOf
Status
Superseded
SupersededBy

Standards Relationship
ISO/TS 12417:2011 Identical

⚠

A newer version of this standard is available.

View Current Edition
US$462.87
Excluding Tax where applicable